Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search help

15 results

  1. Soft Tissue Sarcoma Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK66046
    ... in most clinical settings. A variety of other regimens have been used, but none have increased OS when compared with doxorubicin alone.[ 1 , 2 ] There is some evidence that the addition of ifosfamide (with mesna) to doxorubicin increases response rates and progression-free ...
  2. Childhood Soft Tissue Sarcoma Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65923
    ... Ryan L, Sulkes A, et al.: Response to mesna, doxorubicin, ifosfamide, and dacarbazine in 108 patients with metastatic or ...
  3. Osteosarcoma and Undifferentiated Pleomorphic Sarcoma of Bone Treatment (PDQ®) - PDQ Cancer Information Summaries - ... 
    https://www.ncbi.nlm.nih.gov/books/NBK65736
    ... Miser JS, Kinsella TJ, Triche TJ, et al.: Ifosfamide with mesna uroprotection and etoposide: an effective regimen in the treatment of recurrent sarcomas and other ...
  4. Uterine Sarcoma Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65888
    ... Barrett RJ, et al.: Phase II trial of ifosfamide and mesna in leiomyosarcoma of the ... of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced ...
  5. NLM Digital Collections - Chimeric antigen receptor T-cell therapy for B-cell cancers : effectiveness and value : final ... 
    Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, March 23, 2018
    resource.nlm.nih.gov/101744954
    ... high- dose therapy, NCCN recommends the following chemotherapy regimens, with or ... ifosfamide, mitoxantrone, etoposide). Patients who experience CR or ...
  6. Bladder and Other Urothelial Cancers Screening (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65774
    ... 25 ] and perhaps other alkylating agents, such as ifosfamide (although the use of mesna in conjunction with these agents may reduce the ...
  7. Management - Non-Hodgkin's Lymphoma: Diagnosis and Management - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK385280
    ... consists of combination chemotherapy. The most frequently used regimen is CHOP (cyclophosphamide, vincristine, doxorubicin and prednisolone) which although reasonably well tolerated is ...
  8. Dictionary of Cancer Terms - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65951
    ... ibritumomab tiuxetan ibrutinib IBS ibuprofen ICD ICE ICE ... alpha-2B iFOBT ifosfamide Ig IGF IGF-1R inhibitor OSI-906 IGFR ...
  9. pdf2018MeShTreeHierarchy.pdf 
    https://www.nlm.nih.gov/mesh/2018/download/2018MeShTreeHierarchy.pdf
    ... Alkanesulfonates D02.455.326.146.100.050.490...........................................Mesna D02.455.326.146.100.050.500...........................................Mesylates ...
  10. NLM Digital Collections - Beikoku Kokuritsu Igaku Toshokan bunruihō : igaku oyobi kanren bun'ya ni okeru tosho haikahō 
    Publication: Tōkyō : Nihon Igaku Toshokan Kyōkai, 1996
    resource.nlm.nih.gov/9704321
    ... NAD Coenzyme II see NADP Coenzyme M see Mesna Coenzyme Q see Ubiquinone Coenzymes QU 135 Coercion ... Chlorohydrin 2-Hydroxyphenethylamine QU 61 2-Mercaptoethanesulfonate see Mesna 2-Phenylethanolamine see 2-Hydroxyphenethylamine 2 ',3 -Cyclic- ...
previous · 1 · 2 · next